Related Experiment Video
Updated: Jun 14, 2025

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Is Helicobacter pylori Infection Associated With Ulcerative Colitis Activity?
Ayoung Lee1, Jung Wan Choe1, Sung Woo Jung1
1Division of Gastroenterology, Department of Internal Medicine, Korea University College of Medicine, Ansan, Korea.
Helicobacter pylori infection was found in about 25% of ulcerative colitis patients. This study found no link between H. pylori infection and the severity of ulcerative colitis symptoms or disease activity.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Inflammatory Bowel Disease Research
Background:
- Epidemiological studies suggest an inverse relationship between Helicobacter pylori infection and ulcerative colitis (UC).
- Understanding the potential protective role of H. pylori in UC severity is crucial for patient management.
Purpose of the Study:
- To investigate the association between H. pylori infection and the severity of newly diagnosed ulcerative colitis.
- To determine if H. pylori infection influences endoscopic findings, clinical symptoms, or treatment requirements in UC patients.
Main Methods:
- A retrospective single-center study of 316 patients with newly diagnosed UC.
- H. pylori status was evaluated via upper endoscopy.
- UC severity was assessed using endoscopic findings, clinical symptoms, treatment regimens, and Mayo scores.
Main Results:
- H. pylori infection prevalence was 23.4% in the UC cohort.
- No significant differences were observed in disease extent, endoscopic severity, or UC symptom severity (stool frequency, rectal bleeding) between H. pylori positive and negative groups.
- Steroid use for induction therapy and Mayo scores did not differ significantly between the groups.
Conclusions:
- H. pylori infection was detected in a notable proportion of UC patients but did not correlate with disease severity.
- UC severity, assessed by endoscopic activity, symptoms, steroid use, or Mayo score, was independent of H. pylori infection status.
More Related Videos
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.